RU94013606A - Hemostimulator - Google Patents
HemostimulatorInfo
- Publication number
- RU94013606A RU94013606A RU94013606/14A RU94013606A RU94013606A RU 94013606 A RU94013606 A RU 94013606A RU 94013606/14 A RU94013606/14 A RU 94013606/14A RU 94013606 A RU94013606 A RU 94013606A RU 94013606 A RU94013606 A RU 94013606A
- Authority
- RU
- Russia
- Prior art keywords
- blood
- hemodepression
- cytostatics
- regeneration
- drug
- Prior art date
Links
- 210000004369 Blood Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 230000001085 cytostatic Effects 0.000 claims 3
- 239000000824 cytostatic agent Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 2
- 230000008929 regeneration Effects 0.000 claims 2
- 238000011069 regeneration method Methods 0.000 claims 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18β-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims 1
- GHASVSINZRGABV-UHFFFAOYSA-N 5-flurouricil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 229960002949 Fluorouracil Drugs 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 claims 1
- 230000011132 hemopoiesis Effects 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 230000004936 stimulating Effects 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 230000002588 toxic Effects 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU94013606A RU2088249C1 (en) | 1994-04-18 | 1994-04-18 | Hemostimulating agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU94013606A RU2088249C1 (en) | 1994-04-18 | 1994-04-18 | Hemostimulating agent |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94013606A true RU94013606A (en) | 1995-12-27 |
RU2088249C1 RU2088249C1 (en) | 1997-08-27 |
Family
ID=20154837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94013606A RU2088249C1 (en) | 1994-04-18 | 1994-04-18 | Hemostimulating agent |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2088249C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2423142C1 (en) | 2009-12-02 | 2011-07-10 | Общество С Ограниченной Ответственностью "Парафарм" | Medication for treatment and prevention of urogenital system diseases in males |
-
1994
- 1994-04-18 RU RU94013606A patent/RU2088249C1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200000468A1 (en) | THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY | |
DE69230112T2 (en) | ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE | |
DE69333321D1 (en) | Use of a consensus interferon to reduce the side effects in the interferon treatment of viral hepatites. | |
ATE153856T1 (en) | COMPOSITION FOR STIMULATING THE IMMUNE SYSTEM | |
RU94016393A (en) | PEPTIDES possessing the ability to stimulate the growth of the growth hormone, method of production, pharmaceutical composition, method of treatment | |
PT740650E (en) | CO-DRUGS AS A METHOD OF CONTROLLED DRUG ADMINISTRATION | |
RU95113492A (en) | THERAPEUTIC COMBINATION CONTAINING THE HUMAN INTERFERON, ITS APPLICATION, PHARMACEUTICAL DRUG, PACKAGING AND METHOD OF TREATMENT | |
Steiner et al. | Pentazocine-induced myopathy | |
RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
RU94013606A (en) | Hemostimulator | |
DE69929616D1 (en) | OXYHUMIC ACID AND ITS USE FOR THE TREATMENT OF DIFFERENT DISORDER | |
RU2003113987A (en) | METHOD FOR TREATMENT AND PREVENTION OF DISEASES BY EXPOSURE TO BIOLOGICALLY ACTIVE POINTS AND ZONES | |
FR2786699B1 (en) | MEDICINE, IN PARTICULAR FOR PREVENTING OR TREATING SEXUAL DYSFUNCTIONS | |
RU93016030A (en) | A MEDICINE STIMULATING THE GRANULOSITARY GROWTH OF HEMATOPHONYA IN CYTOSTATIC MYELODEPRESSIONS | |
RU92013625A (en) | DRUGS, STIMULATING ERYTHROID GROWTH BLOOD DURING CYTOSTATIC MYELOPRESSIONS | |
RU95113855A (en) | METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS | |
SU1261662A1 (en) | Method of treatment of syndrome of anterior scalene muscle | |
ATE291919T1 (en) | USE OF ADATANSERIN FOR THE TREATMENT OF ACUTE NEURODEGENERATIVE DISEASES | |
RU93034376A (en) | DRUG STIMULATING ERYTHROID AND GRANULOCITARY HEMORRHAGE GROWTH DURING CYTOSTATIC MYELODEPRESSIONS | |
RU95102718A (en) | Method of immune status correction in hiv-infected patients | |
RU97111543A (en) | METHOD FOR TREATING NEUROLOGICAL DISORDERS RELATED TO THE CHRONIC FORM OF CONGENITAL VIRAL INFECTION | |
UA29910A (en) | A METHOD OF TREATMENT OF DYSFUNCTION OF THE PARTIAL-LOWER-JAW JOINT | |
MD1469G2 (en) | Method of treatment of the burn shock | |
RU98110897A (en) | METHOD FOR IMMUNOTHERAPY OF CHRONIC INFLAMMATORY DISEASES | |
RU93037848A (en) | METHOD OF TREATMENT OF LEPROI PATIENTS |